My Quote Request
No products added yet
6505-01-283-1331
20 Products
NDC00137-8919-01
LUBRICANT,SURGICAL
NSN, MFG P/N
6505012831331
NSN
6505-01-283-1331
MFG
JOHNSON & JOHNSON SALES AND LOGISTICS COMPANY LLC
Description
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: 12 TUBES PER PG; 6 DZ./CS
Related Searches:
KY LUBE JELLY
LUBRICANT,SURGICAL
NSN, MFG P/N
6505012831331
NSN
6505-01-283-1331
MFG
GENERAL MEDICAL CORP
Description
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: 12 TUBES PER PG; 6 DZ./CS
Related Searches:
NDC51079-0226-32
ALUMINUM HYDROXIDE GEL,USP
NSN, MFG P/N
6505012832364
NSN
6505-01-283-2364
NDC51079-0226-32
ALUMINUM HYDROXIDE GEL,USP
NSN, MFG P/N
6505012832364
NSN
6505-01-283-2364
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 61.000 MILLIGRAMS ALUMINUM HYDROXIDE PER MILLIGRAM
ADMINISTRATION: ORAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00536-3919-50
HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505012832721
NSN
6505-01-283-2721
NDC00536-3919-50
HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505012832721
NSN
6505-01-283-2721
MFG
BLAIR INDUSTRIES INC. DBA BLAIR PACKAGING
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
063909
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012832722
NSN
6505-01-283-2722
MFG
SUNOCO INC. DBA SUNOCO DIV WHOLESALE FUELS MARKETING
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PROTECTIVE STORAGE FEATURE:SECURITY STORAGE;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
Related Searches:
29875
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012832722
NSN
6505-01-283-2722
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PROTECTIVE STORAGE FEATURE:SECURITY STORAGE;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
Related Searches:
NDC00003-0298-75
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012832722
NSN
6505-01-283-2722
NDC00003-0298-75
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012832722
NSN
6505-01-283-2722
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PROTECTIVE STORAGE FEATURE:SECURITY STORAGE;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
Related Searches:
NDC00536-3959-10
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012832722
NSN
6505-01-283-2722
NDC00536-3959-10
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012832722
NSN
6505-01-283-2722
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PROTECTIVE STORAGE FEATURE:SECURITY STORAGE;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
Related Searches:
16130
SULFAMETHOXAZOLE AND TRIMETHOPRIM CONCENTRATE FOR INJECTION,USP
NSN, MFG P/N
6505012833658
NSN
6505-01-283-3658
16130
SULFAMETHOXAZOLE AND TRIMETHOPRIM CONCENTRATE FOR INJECTION,USP
NSN, MFG P/N
6505012833658
NSN
6505-01-283-3658
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 16.000 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: STERILE SOLUTION
Related Searches:
NDC00469-1610-50
SULFAMETHOXAZOLE AND TRIMETHOPRIM CONCENTRATE FOR INJECTION,USP
NSN, MFG P/N
6505012833658
NSN
6505-01-283-3658
NDC00469-1610-50
SULFAMETHOXAZOLE AND TRIMETHOPRIM CONCENTRATE FOR INJECTION,USP
NSN, MFG P/N
6505012833658
NSN
6505-01-283-3658
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 16.000 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: STERILE SOLUTION
Related Searches:
NDC00641-2766-41
SULFAMETHOXAZOLE AND TRIMETHOPRIM CONCENTRATE FOR INJECTION,USP
NSN, MFG P/N
6505012833658
NSN
6505-01-283-3658
NDC00641-2766-41
SULFAMETHOXAZOLE AND TRIMETHOPRIM CONCENTRATE FOR INJECTION,USP
NSN, MFG P/N
6505012833658
NSN
6505-01-283-3658
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 16.000 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: STERILE SOLUTION
Related Searches:
NDC00409-6535-01
VANCOMYCIN HYDROCHLORIDE,STERILE,USP
NSN, MFG P/N
6505012833663
NSN
6505-01-283-3663
NDC00409-6535-01
VANCOMYCIN HYDROCHLORIDE,STERILE,USP
NSN, MFG P/N
6505012833663
NSN
6505-01-283-3663
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS VANCOMYCIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VANCOMYCIN HYDROCHLORIDE STERILE USP 1GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML CAPACITY GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION; 6505-01-260-1237; 6505-01-260-1238; 6505-01-260-1239; AND SODIUM CHLORIDE INJECTION; 6505-01-260-1241; 6505-01-260-1242; AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
VANCOCIN
VANCOMYCIN HYDROCHLORIDE,STERILE,USP
NSN, MFG P/N
6505012833663
NSN
6505-01-283-3663
VANCOCIN
VANCOMYCIN HYDROCHLORIDE,STERILE,USP
NSN, MFG P/N
6505012833663
NSN
6505-01-283-3663
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS VANCOMYCIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VANCOMYCIN HYDROCHLORIDE STERILE USP 1GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML CAPACITY GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION; 6505-01-260-1237; 6505-01-260-1238; 6505-01-260-1239; AND SODIUM CHLORIDE INJECTION; 6505-01-260-1241; 6505-01-260-1242; AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
VANCOCIN ADD-VANTAGE
VANCOMYCIN HYDROCHLORIDE,STERILE,USP
NSN, MFG P/N
6505012833663
NSN
6505-01-283-3663
VANCOCIN ADD-VANTAGE
VANCOMYCIN HYDROCHLORIDE,STERILE,USP
NSN, MFG P/N
6505012833663
NSN
6505-01-283-3663
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS VANCOMYCIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VANCOMYCIN HYDROCHLORIDE STERILE USP 1GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML CAPACITY GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION; 6505-01-260-1237; 6505-01-260-1238; 6505-01-260-1239; AND SODIUM CHLORIDE INJECTION; 6505-01-260-1241; 6505-01-260-1242; AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
NDC59011-0262-10
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012833664
NSN
6505-01-283-3664
NDC59011-0262-10
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012833664
NSN
6505-01-283-3664
MFG
PURDUE PHARMA L.P.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE TABLETS 60MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: DESIGNED TO BE RELEASED OVER 12 HOURS
Related Searches:
NDC66479-0542-10
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012833664
NSN
6505-01-283-3664
NDC66479-0542-10
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012833664
NSN
6505-01-283-3664
MFG
XANODYNE PHARMACEUTICALS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE TABLETS 60MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: DESIGNED TO BE RELEASED OVER 12 HOURS
Related Searches:
RL-100
WATER,PURIFIED,MODIFIED
NSN, MFG P/N
6505012835257
NSN
6505-01-283-5257
MFG
LABORATORY SUPPLY CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 GALLONS WATER, PURIFIED ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 GALLONS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: DEIONIZED; NONSTERILIZED
Related Searches:
NDC00023-0667-04
LUBRICANT,OPHTHALMIC
NSN, MFG P/N
6505012837955
NSN
6505-01-283-7955
NDC00023-0667-04
LUBRICANT,OPHTHALMIC
NSN, MFG P/N
6505012837955
NSN
6505-01-283-7955
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 55.000 PERCENTAGE, W/V PETROLATUM ACTIVE INGREDIENT AND 41.500 PERCENTAGE, W/V MINERAL OIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT OPHTHALMIC 3.5GM OR .120OZ PLASTIC TUBE 12S
PRIMARY CONTAINER CONTENT QUANTITY: 3.500 GRAMS OR 0.120 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
REFRESH PM
LUBRICANT,OPHTHALMIC
NSN, MFG P/N
6505012837955
NSN
6505-01-283-7955
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 55.000 PERCENTAGE, W/V PETROLATUM ACTIVE INGREDIENT AND 41.500 PERCENTAGE, W/V MINERAL OIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT OPHTHALMIC 3.5GM OR .120OZ PLASTIC TUBE 12S
PRIMARY CONTAINER CONTENT QUANTITY: 3.500 GRAMS OR 0.120 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NAPROSYN TABLETS
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012840271
NSN
6505-01-284-0271
NAPROSYN TABLETS
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012840271
NSN
6505-01-284-0271
MFG
SYNTEX LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: UNIT OF USE
